Exact Sciences Corp.
EXAS
Market Cap$10B
Close$
$-38.07
171.8% downside
Current Fair Value
171.8% downsideOvervalued by 171.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.00 Billion |
|---|---|
| Enterprise Value | $12.18 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-5.59 |
| Beta | 0.98 |
| Outstanding Shares | 186,813,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.71 |
|---|---|
| PEG | 118.78 |
| Price to Sales | 3.53 |
| Price to Book Ratio | 4.42 |
| Enterprise Value to Revenue | 4.31 |
| Enterprise Value to EBIT | -11.57 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 1.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Exact Sciences Corp.
CEO: Kevin Conroy